Palisades Hudson Asset Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Palisades Hudson Asset Management's MRK Position: Q1 2020 in Review
Palisades Hudson Asset Management sold out of Merck (MRK) in Q1 2020, closing a stake of 2,644 shares — an estimated $229K sold.
Palisades Hudson Asset Management first reported a position in MRK in Q1 2014 and held it in 21 quarters. The position peaked at $292K in Q4 2018. 2,477 funds tracked by Wall St. Rank hold MRK as of Q1 2020.
- Palisades Hudson Asset Management reported no remaining Merck position as of Q1 2020 after selling out during the quarter.
- Palisades Hudson Asset Management sold 2,644 Merck shares in Q1 2020, an estimated $229K.
- Palisades Hudson Asset Management first reported a position in Merck in Q1 2014 and held it in 21 quarters.
- Palisades Hudson Asset Management's Merck position peaked at $292K in Q4 2018.
- 2,477 funds tracked by Wall St. Rank held Merck as of Q1 2020.
Based on Palisades Hudson Asset Management's 13F filing for Q1 2020, filed 7 May 2020.